Cargando…
Predictors and Interrelationship of Patient‐Reported Outcomes in Antiphospholipid Syndrome: A Cross‐Sectional Study
OBJECTIVE: This study assessed patient‐reported outcomes (PROs) in individuals with persistently positive antiphospholipid antibodies (aPL) to better understand how living with aPL may affect their quality of life. METHODS: Patients completed Patient‐Reported Outcomes Measurement Information System...
Autores principales: | Weiner, Julia K., Smith, Tristin, Hoy, Claire K., Sarosh, Cyrus, Madison, Jacqueline A., Ambati, Amala, Tambralli, Ajay, Peters, Noah, Packel, Corinne, Gockman, Kelsey, Zuo, Yu, Briceño, Emily M., Nagaraja, Vivek, Knight, Jason S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley Periodicals, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9837395/ https://www.ncbi.nlm.nih.gov/pubmed/36461647 http://dx.doi.org/10.1002/acr2.11512 |
Ejemplares similares
-
Pediatric antiphospholipid syndrome: clinical features and therapeutic interventions in a single center retrospective case series
por: Madison, Jacqueline A., et al.
Publicado: (2022) -
Autoantibodies stabilize neutrophil extracellular traps in COVID-19
por: Zuo, Yu, et al.
Publicado: (2021) -
Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 patients
por: Zuo, Yu, et al.
Publicado: (2021) -
Endothelial Cell–Activating Antibodies in COVID‐19
por: Shi, Hui, et al.
Publicado: (2022) -
Antiphospholipid syndrome: a clinical perspective
por: Zuo, Yu, et al.
Publicado: (2020)